Daniel A. Goldstein, MD of Davidoff Cancer Center gives an overview of the treatment trends for non-small cell lung cancer for 2017, which include new approvals for immunotherapies. This was recorded at the 2017 ASCO Annual Meeting in Chicago, IL
Advertisement
Advertisement